Characterization of early onset neurofibromatosis type 2

被引:19
|
作者
Matsuo, Muneaki [1 ]
Ohno, Kousaku [2 ]
Ohtsuka, Fujio [3 ]
机构
[1] Saga Univ, Dept Pediat, Fac Med, Saga 8498501, Japan
[2] Tottori Univ, Fac Med, Dept Child Neurol, Yonago, Tottori 683, Japan
[3] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan
来源
BRAIN & DEVELOPMENT | 2014年 / 36卷 / 02期
关键词
Neurofibromatosis type 2 (NF2); Childhood; Prognosis; GENE; NF2; AGE;
D O I
10.1016/j.braindev.2013.01.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurofibromatosis type 2 (NF2) is an autosomal dominant multiple neoplasia syndrome of the central nervous system. The aim of the present study was to characterize the clinical course of early onset NF2. The specific Japanese disease registry for NF2 in 2010 was analyzed retrospectively. The male:female ratio for the 312 patients identified in the database was 1:1.29. The median age at onset was 25 years (range 2-76 years), with 31.3% of patients exhibiting symptoms at <20 years of age. Patients with an age at onset of <20 years were found to have more frequent spinal cord and extravestibular cranial nerve involvement, cutaneous signs, and convulsions than patients with a later age at onset. Of patients younger than 18 years of age, half did not exhibit hearing problems; in contrast, they frequently had other cranial nerve schwannomas, cranial meningioma, spinal cord tumors, and subcutaneous schwannoma. There were weak but significant positive correlations between symptomatic periods and disability scores in patients with an age of onset of >= 20 years (R = 0.225; P < 0.01) and those with an earlier age of onset (R = 0.306; P < 0.01). Although there were no significant differences in disability scores between genders or patients with an age at onset of <20 versus >= 20 years, patients with an earlier age at onset had significantly higher disability scores for spinal symptoms than patients with an age at onset of >= 20 years. Atypical extravestibular presentation is common in early onset NF2, with more prominent spinal symptoms. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [21] NEUROFIBROMATOSIS TYPE 2
    Kalamarides, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 630 - 630
  • [22] Neurofibromatosis type 2
    Asthagiri, Ashok R.
    Parry, Dilys M.
    Butman, John A.
    Kim, H. Jeffrey
    Tsilou, Ekaterini T.
    Zhuang, Zhengping
    Lonser, Russell R.
    LANCET, 2009, 373 (9679): : 1974 - 1986
  • [23] EARLY PRESENTATION OF NEUROFIBROMATOSIS TYPE 1
    Thimmappa, T. D.
    Gangadhar, K. S.
    Shetty, Harshavardhan Kushal
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (26): : 4672 - 4675
  • [24] Early Onset of Type 2 Diabetes in Pune
    Srivastava, Sharmistha Aich
    STUDIES ON ETHNO-MEDICINE, 2013, 7 (02) : 95 - 99
  • [25] Neurofibromatosis type 2
    Evans, DGR
    Sainio, M
    Baser, ME
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (12) : 897 - 904
  • [26] Neurofibromatosis type 2
    Sathornsumetee, S.
    DesJardins, A.
    Reardon, D. A.
    Rich, J. N.
    Vredenburgh, J. J.
    NEUROLOGY, 2007, 68 (13) : E14 - E14
  • [27] Early/onset type 2 diabetes in Mexico
    García-García, E
    Aguilar-Salinas, CA
    Tusié-Luna, T
    Rull-Rodrigo, JA
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (06): : 444 - 448
  • [28] Neurofibromatosis type 2
    Perez-Grau, Marta
    Miro, Nuria
    Prades, Jose
    Verges, Juan
    Lareo, Susana
    Roca-Ribas, Francesc
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2010, 61 (04): : 306 - 311
  • [29] Neurofibromatosis type 2
    Caldemeyer, KS
    Mirowski, GW
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) : 744 - 745
  • [30] Neurofibromatosis type 2
    Uppal, S
    Coatesworth, AP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (08) : 698 - 703